Amitriptyline
Nerve Pain
University of Sao PauloSmall moleculePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Nerve Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Ataturk University | Phase 4 | BBB |
Bxcl501 University Medical Centre Ljubljana | Phase 4 | BBB |
NEPENTHE Alexandria University | Phase 3 | BB |
Epicept-Np-1 Cream EpiCept Corporation | Phase 2 | B |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- EpiCept Corporation | Phase 2 | B |
ROPIVACAINE Women's College Hospital | Phase 2 | B |
azd2423 AstraZeneca | Phase 2 | B |
FTC-146 Stanford University | Phase 1 | CC |
Same molecule, other indications
Amitriptyline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →